OBERWEIS ASSET MANAGEMENT INC/
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 937886
LISLE, IL
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,413,524
+$11,071,297 QoQ
Shares Held
413,034
+29.6% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#31
of 266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OBERWEIS ASSET MANAGEMENT INC/ holds $140,674,369 across 6 Drug Manufacturers - Specialty & Generic names. KNSA ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
406,400 | $32,402,272 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
779,188 | $31,970,083 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
413,034 | $26,413,524 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
265,306 | $21,962,030 | |
| 5 | ETON |
Eton Pharmaceuticals, Inc.
|
501,600 | $18,157,920 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
311,100 | $9,768,540 |
All Filings in KNSA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,413,524 | 413,034 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,342,227 | 318,634 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,903,000 | 312,800 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,850,916 | 305,200 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,444,884 | 305,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,268,212 | 237,200 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,691,816 | 237,200 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,022,990 | 201,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||